Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria.

Autor: Joseph A; NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, Nigeria., Olatosi B; Health Services, Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC., Haider MR; Department of Health Policy and Management, College of Public Health, University of Georgia, Athens, GA., Adegboyega BC; NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, Nigeria., Lasebikan NN; University of Nigeria Teaching Hospital, Enugu, Nigeria., Aliyu UM; Usman Danfodiyo University Teaching Hospital, Sokoto, Nigeria., Ali-Gombe M; Federal Teaching Hospital, Gombe, Nigeria., Jimoh MA; University College Hospital, Ibadan, Oyo, Nigeria.; Lakeshore Cancer Center, Lagos, Nigeria., Biyi-Olutunde OA; University of Port-Harcourt Teaching Hospital, Port-Harcourt, Rivers State, Nigeria., Awofeso O; Lagos University Teaching Hospital, Idiaraba, Lagos, Nigeria., Fatiregun OA; Department of Radiology, Lagos State University Teaching Hospital (LASUTH), Lagos, Nigeria., Oboh EO; University of Benin Teaching Hospital, Edo, Nigeria., Nwachukwu E; National Hospital, Abuja, Federal Capital Territory, Nigeria., Zubairu IH; Ahmadu Bello University Teaching Hospital, Kaduna, Nigeria., Otene SA; Federal Medical Centre, Makurdi, Borno, Nigeria., Iyare OI; Alex Ekwueme Federal Teaching Hospital Abakaliki, Ebonyi, Nigeria., Andero T; Eko Hospital, Lagos, Nigeria., Musbau AB; Federal Medical Centre, Abeokuta, Ogun, Nigeria., Ajose A; Lagos University Teaching Hospital, Idiaraba, Lagos, Nigeria., Onitilo AA; Department of Oncology, Marshfield Clinic Health System, Marshfield, WI.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2022 Feb; Vol. 8, pp. e2100244.